Compugen Ltd Financial Statements (CGEN)
|
|
|
|
Report date
|
|
|
28.02.2022 |
28.02.2023 |
05.03.2024 |
04.03.2025 |
02.03.2026 |
|
18.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
6.00 |
7.50 |
33.5 |
27.9 |
72.8 |
|
72.7 |
|
Operating Income, bln rub |
|
|
-35.1 |
-35.4 |
-13.0 |
-14.9 |
31.3 |
|
30.7 |
|
EBITDA, bln rub |
? |
|
-34.6 |
-33.1 |
-12.5 |
-14.4 |
35.9 |
|
34.1 |
|
Net profit, bln rub |
? |
|
-34.2 |
-33.7 |
-18.8 |
-14.2 |
35.3 |
|
34.9 |
|
|
OCF, bln rub |
? |
|
-22.8 |
-34.5 |
-35.9 |
49.6 |
31.6 |
|
0.000 |
|
CAPEX, bln rub |
? |
|
0.292 |
0.487 |
0.172 |
0.118 |
0.306 |
|
0.000 |
|
FCF, bln rub |
? |
|
-23.0 |
-35.0 |
-36.1 |
49.5 |
31.3 |
|
0.000 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
40.4 |
41.9 |
44.4 |
34.8 |
32.2 |
|
33.3 |
|
Cost of production, bln rub |
|
|
0.680 |
0.975 |
2.00 |
7.93 |
9.25 |
|
8.68 |
|
R&D, bln rub |
|
|
28.7 |
30.6 |
34.5 |
24.8 |
22.8 |
|
23.9 |
|
Interest expenses, bln rub |
|
|
0.025 |
0.027 |
0.031 |
0.034 |
0.000 |
|
0.000 |
|
|
Assets, bln rub |
|
|
132.2 |
94.2 |
121.3 |
115.0 |
156.9 |
|
145.9 |
|
Net Assets, bln rub |
? |
|
106.7 |
77.7 |
65.6 |
54.9 |
102.7 |
|
95.4 |
|
Debt, bln rub |
|
|
2.75 |
1.93 |
1.35 |
2.91 |
2.96 |
|
2.93 |
|
Cash, bln rub |
|
|
117.0 |
83.3 |
50.7 |
103.3 |
145.6 |
|
134.9 |
|
Net debt, bln rub |
|
|
-114.3 |
-81.4 |
-49.3 |
-100.3 |
-142.7 |
|
-132.0 |
|
|
Ordinary share price, rub |
|
|
4.30 |
|
|
1.53 |
1.53 |
|
2.02 |
|
Number of ordinary shares, mln |
|
|
84.2 |
86.6 |
87.6 |
89.5 |
93.4 |
|
94.6 |
|
|
Market cap, bln rub |
|
|
362 |
0 |
0 |
137 |
143 |
|
191 |
|
EV, bln rub |
? |
|
248 |
-81 |
-49 |
37 |
0 |
|
59 |
|
Book value, bln rub |
|
|
107 |
78 |
66 |
55 |
103 |
|
95 |
|
|
EPS, rub |
? |
|
-0.41 |
-0.39 |
-0.21 |
-0.16 |
0.38 |
|
0.37 |
|
FCF/share, rub |
|
|
-0.27 |
-0.40 |
-0.41 |
0.55 |
0.34 |
|
0 |
|
BV/share, rub |
|
|
1.27 |
0.90 |
0.75 |
0.61 |
1.10 |
|
1.01 |
|
|
EBITDA margin, % |
? |
|
-576.9% |
-441.7% |
-37.4% |
-51.7% |
49.3% |
|
46.9% |
|
Net margin, % |
? |
|
-570.1% |
-449.3% |
-56.1% |
-51.1% |
48.6% |
|
48.0% |
|
FCF yield, % |
? |
|
-6.36% |
|
|
36.1% |
21.9% |
|
0.00% |
|
ROE, % |
? |
|
-32.1% |
-43.4% |
-28.6% |
-25.9% |
34.4% |
|
36.6% |
|
ROA, % |
? |
|
-25.9% |
-35.8% |
-15.5% |
-12.4% |
22.5% |
|
23.9% |
|
|
P/E |
? |
|
-10.6 |
0.00 |
0.00 |
-9.63 |
4.04 |
|
5.48 |
|
P/FCF |
|
|
-15.7 |
0.00 |
0.00 |
2.77 |
4.56 |
|
|
|
P/S |
? |
|
60.3 |
0.00 |
0.00 |
4.92 |
1.96 |
|
2.63 |
|
P/BV |
? |
|
3.39 |
0.00 |
0.00 |
2.49 |
1.39 |
|
2.00 |
|
EV/EBITDA |
? |
|
-7.16 |
2.46 |
3.94 |
-2.54 |
0.01 |
|
1.73 |
|
Debt/EBITDA |
|
|
3.30 |
2.46 |
3.94 |
6.97 |
-3.98 |
|
-3.87 |
|
|
R&D/CAPEX, % |
|
|
9 827% |
6 293% |
20 042% |
21 025% |
7 437% |
|
|
|
|
CAPEX/Revenue, % |
|
|
4.87% |
6.49% |
0.51% |
0.42% |
0.42% |
|
0 |
|
| Compugen Ltd shareholders |
